Global Fluorescence-Guided Surgery System Market Set to Soar, Projected to Reach USD 468 Million by 2034

Fluorescence-Guided Surgery System Market

According to Future Market Insights (FMI), the global fluorescence-guided surgery system market is projected to reach USD 110.8 million in 2024 and USD 468 million by 2034. The market is anticipated to rise at a CAGR of 15.5% from 2024 to 2034.

Increasing surgeries for cancer and cardiovascular diseases are projected to boost the usage of fluorescence-guided surgery systems. The industry is undergoing a rapid digital transformation, leveraging technologies like AI, IoT, and blockchain for enhanced efficiency and personalized customer experiences.

Get Recently Updated Sample Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-19603

Consumers are prioritizing health and wellness, leading to the rise of functional and nutritious products in the fluorescence-guided surgery system market. Key companies are exploring opportunities in emerging markets, escalating their expertise and resources to expand their presence and tap into new customer segments.

Fluctuations in raw material prices are set to affect profit margins and operational costs, exposing companies in the market to financial risks. Furthermore, changes in consumer preferences are projected to lead to decreased demand for products or services, affecting the market’s relevance.

Key Takeaways from the Fluorescence Guided Surgery System Market Report:

• The fluorescence-guided surgery system market is expected to reach a valuation of USD 468 million by 2034.
• The market is projected to surge at a CAGR of 15.5% by 2034.
• China’s fluorescence-guided surgery system market is expected to grow at a CAGR of 16.3% by 2034.
• The United States is projected to reach a valuation of USD 84.5 million in 2034.
• Based on type, the SPY system segment held a market share of 34% in 2023.

“Technological advancements and changing consumer preferences are set to fuel expansion in the fluorescence-guided surgery system industry. Leading companies are also projected to benefit from rising demand, favorable regulatory environments, and a growing focus on sustainability.” – says a lead analyst at Future Market Insights (FMI)

Customization with Our Report: https://www.futuremarketinsights.com/customization-available/rep-gb-19603

Competitive Landscape:

Stryker Corporation, Olympus Corporation, Medtronic PLC, OnLume Inc., and Getinge AB are key fluorescence-guided surgery system manufacturers listed in the report. Leading manufacturers employ strategies such as mergers, acquisitions, partnerships, distribution agreements, collaborations, advertisements, and celebrity endorsements. This helps key companies enhance brand visibility, establish credibility, and gain a competitive advantage in the dynamic landscape.

Industry Updates,

• In 2023, Unify Medical and the Mayo Clinic partnered to develop medical devices using Unify’s fluorescence-guided visualization technology.
• In 2024, Leica Microsystems introduced an updated version of its ARveo 8 digital visualization microscope, which enhances surgical visualization in neurosurgery.

Leading Fluorescence Guided Surgery System Brands:

• Stryker Corporation
• Hamamatsu Photonics K.K.
• Olympus Corporation
• Medtronic PLC
• OnLume Inc.
• Getinge AB
• Curadel LLC
• PerkinElmer, Inc.
• Karl Storz SE & Co. KG
• Irillic Pvt. Ltd
• Shimadzu Corporation

A Full Report Analysis: https://www.futuremarketinsights.com/checkout/19603

Key Segments of Market Report:

By Type:

The industry is segregated into SPY system, PDE system, VS3 iridium system, and others.

By Surgery:

In terms of surgeries, the industry is divided into open surgery and laparoscopy/endoscopy.

By Application:

A few of the important applications include cancer surgeries, cardiovascular surgeries, and others.

By Region:

Key countries of North America, Latin America, East Asia, South Asia and Pacific, Western Europe, Eastern Europe, and the Middle East and Africa are covered.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube